DRUGS/PRESCRIPTION: Prohibits a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2018
Committee Review
Floor Vote
Governor
Introduced Feb 28, 2018
Last action Apr 17, 2018
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
9
Key actions
0
Committee
4
Amendments
1
Apr 11, 2018
Legislature · Amendment offered
Reported with amendments (7-0).
Apr 6, 2018
Legislature · Referred to committee
Read by title, amended, ordered engrossed, recommitted to the Committee on House and Governmental Affairs.
Apr 5, 2018
Legislature · Referred to committee
Reported with amendments (12-0). To be recommitted to the Committee on House and Governmental Affairs.
Mar 12, 2018
Legislature · Referred to committee
Read by title, rules suspended, referred to the Committee on Health and Welfare.
Feb 28, 2018
Legislature · Referred to committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
0 primary · 0 co-sponsors
Sponsors
No sponsor information available.
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 243
Scope: LA
Hi! I can help you understand HB 243. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline